Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/41833
Title: Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project.
Authors: 
Keywords: 
Issue Date: May-2017
Citation: ESC Heart Fail.2017 May;(4)2:130-137
Abstract: Hyponatraemia is an electrolyte disorder that occurs in advanced congestive heart failure (HF) and worsens prognosis. We explored the usefulness of tolvaptan, which has shown promising results in the treatment of this condition.
PMID: 28451449
URI: https://hdl.handle.net/20.500.12530/41833
Rights: openAccess
ISSN: 2055-5822
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos

Files in This Item:
File Description SizeFormat 
PMC5396041.pdf190.43 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.